Nitric oxide in damage, disease and repair of the peripheral nervous system

Cellular and Molecular Biology

Volumn 51, Issue 3, 2005, Pages 255-267

  Zochodne, D W ^a   Levy, D ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Nerve blood flow; Pain; Peripheral nerve; Regeneration

Indexed keywords

MYELIN; NITRIC OXIDE;

CENTRAL NERVOUS SYSTEM; GROWTH CONE; HUMAN; INFLAMMATION; MUSCLE; NERVE FIBER; NERVE GROWTH; NERVE INJURY; NERVE REGENERATION; NEUROPATHIC PAIN; NEUROPATHY; NITRERGIC NERVE; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD DORSAL HORN;

AFFERENT PATHWAYS; ANIMALS; DIABETIC NEUROPATHIES; HUMANS; INFLAMMATION; MYELIN SHEATH; NERVE REGENERATION; NITRIC OXIDE; PAIN; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; WALLERIAN DEGENERATION;

WALLERIA;

EID: 30744467942     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: None     Document Type: Review

References (130)

1. Aley, K.O., McCarter, G. and Levine, J.D., Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci. 1998, 18: 7008-7014.
2. Aulak, K.S., Koeck, T., Crabb, J.W. and Stuehr, D.J., Dynamics of protein nitration in cells and mitochondria. Am. J. Physiol. Heart Circ. Physiol. 2004, 286: H30-H38.
3. Bennett, G.J. and Xie, Y.K., A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33: 87-107.
4. Brain, S.D. and Grant, A.D., Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol. Rev. 2004, 84: 903-934.
5. Brett, F.M., Kalichman, M.W., Calcutt, N.A. and Mizisin, A.P., Effects of seven days of galactose feeding and aldose reductase inhibition on mast cells and vessel morphometry in rat sciatic nerve. J. Neurol. Sci. 1996, 141: 6-12.
6. Brownlee, M., Cerami, A. and Vlassara, H., Advanced glycosylation end products in tissue and the biochemical basis of diabetic. N. Engl. J. Med. 1988, 318: 1315-1321.
7. Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P. and Cerami, A., Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986, 232: 1629-1632.
8. Bucala, R., Tracey, K.J. and Cerami, A., Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 1991, 87: 432-438.
9. Cajal, S.R.Y., Degeneration and regeneration of the nervous system. In: Cajal's Degeneration and Regeneration of the Nervous System, DeFelipe, J. et al., (eds.) Oxford University Press, Oxford, 1928.
10. Calver, A., Collier, J. and Vallance, P., Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J. Clin. Invest. 1992, 90: 2548-2554.
11. Cameron, N.E., Cotter, M.A., Dines, K.C. and Maxfield, E.K., Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 1993, 36: 516-522.
12. Cameron, N.E., Cotter, M.A. and Hohman, T.C., Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia 1996, 39: 172-182.
13. Cameron, N.E., Cotter, M.A. and Low, P.A., Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am. J. Physiol. 1991, 261: E1-E8.
14. Cheng, C. and Zochodne, D.W., In vivo proliferation, migration and phenotypic changes of Schwann cells in the presence of myelinated fibers. Neuroscience 2003, 11: 321-329.
15. Conti, G., Rostami, A., Scarpini, E., Baron, P., Galimberti, D., Bresolin, N., Contri, M., Palumbo, C. and De Pol, A., Inducible nitric oxide synthase (iNOS) in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. Exp. Neurol. 2004, 187: 350-358.
16. de la Hoz, C.L., Oliveira, A.L., Queiroz, L.S. and Langone, F., Wallerian degeneration in C57BL/6J and A/J mice: differences in time course of neurofilament and myelin breakdown, macrophage recruitment and iNOS expression. J. Anat. 2003, 203: 567-578.
17. Diederich, D., Skopec, J., Diederich, A. and Dai, F.X., Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am. J. Physiol. 1994, 266: H1153-H1161.
18. Dupuis, J., Endothelin receptor antagonists and their developing role in cardiovascular therapeutics. Can. J. Cardiol. 2000, 16: 903-910.
19. Durante, W., Sen, A.K. and Sunahara, F.A., Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br. J. Pharmacol. 1988, 94: 463-468.
20. Durate, I.D., Lorenzetti, B.B. and Ferreira, S.H., Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J. Pharmacol. 1990, 186: 289-293.
21. Dyck, P.J., Hypoxic neuropathy: Does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture. Neurology 1989, 39: 111-118.
22. Dyck, P.J. and Giannini, C., Pathologic alterations in the diabetic neuropathies of humans: a review. J. Neuropathol. Exp. Neurol. 1996, 55: 1181-1193.
23. Dyck, P.J., Hansen, S., Karnes, J., O'Brien, P., Yasuda, H., Windebank, A. and Zimmerman, B., Capillary number and percentage closed in human diabetic sural nerve. Proc. Natl. Acad. Sci. USA 1985, 82: 2513-2517.
24. Dyck, P.J., Karnes, J.L., O'Brien, P., Okazaki, H., Lais, A. and Engelstad, J., The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann. Neurol. 1986, 19: 440-449.
25. Dyck, P.J., Lais, A., Karnes, J.L., O'Brien, P. and Rizza, R., Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann. Neurol. 1986, 19: 425-439.
26. Elliott, T.G., Cockcroft, J.R., Groop, P.H., Viberti, G.C. and Ritter, J.M., Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin. Sci. 1993, 85: 687-693.
27. Ferreira, S.H., Duarte, I.D. and Lorenzetti, B.B., The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur. J. Pharmacol. 1991, 201: 121-122.
28. Glass, J.D., Brushart, T.M., George, E.B. and Griffin, J.W., Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. J. Neurocytol. 1993, 22: 311-321.
29. Goettl, V.M. and Larson, A.A., Nitric oxide mediates long-term hyperalgesic and antinociceptive effects of the N-terminus of substance P in the formalin assay in mice. Pain 1996, 67: 435-441.
30. Gupta, S., Sussman, I., McArthur, C.S., Tornheim, K., Cohen, R.A. and Ruderman, N.B., Endothelium-dependent inhibition of (Na+)-K+ ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium- derived nitric oxide. J. Clin. Invest. 1992, 90: 727-732.
31. Haley J.E., Dickenson, A.H. and Schachter, M., Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992, 31: 251-258.
32. Hargreaves, K., Dubner, R., Brown, F., Flores, C. and Joris, J., A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32: 77-88.
33. Henrich, M., Hoffmann, K., Konig, P., Grass, M., Fischbach, T., Godecke, A., Hempelmann, G. and Kummer, W., Sensory neurons respond to hypoxia with NO production associated with mitochondria. Mol. Cell Neurosci. 2002, 20: 307-322.
34. Henrich, M., Paddenberg, R., Haberberger, R.V., Scholz, A., Gruss, M., Hempelmann, G. and Kummer, W., Hypoxic increase in nitric oxide generation of rat sensory neurons requires activation of mitochondrial complex II and voltage-gated calcium channels. Neuroscience 2004, 128: 337-345.
35. Hess, D.T., Patterson, S.I., Smith, D.S. and Skene, J.H., Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 1993, 366: 562-565.
36. Hickey, M.J., Sharkey K.A., Sihota, E.G., Reinhardt, P.H., Macmicking, J.D., Nathan, C. and Kubes, P., Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 1997, 11: 955-964.
37. Hill, M.A., Meininger, G.A. and Larkins, R.G., Alterations in microvascular reactivity in experimental diabetes mellitus: contribution of the endothelium? In: Endothelial Cell Function in Diabetic Microangiopathy: Problems in Methodology and Clinical Aspects, Molinatti, G.M. and et al. (eds.) Karger, Basel, 1990, pp. 118-126.
38. Holthusen, H. and Arndt, J.O., Nitric oxide evokes pain at nociceptors of the paravascular tissue and veins in humans. J. Physiol. 1995, 487: 253-258.
39. Huang, T.J., Price, S.A., Chiton, L., Calcutt, N.A., Tomlinson, D.R., Verkhratsky, A. and Fernyhough, P., Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 2003, 52: 2129-2136.
40. Ido, Y., Chang, K., LeJeune, W., Tilton, R.G., Monafo, W.W. and Williamson, J.R., Diabetes impairs sciatic nerve hyperemia induced by surgical trauma: implications for diabetic neuropathy. Am. J. Physiol. 1997, 273: E174-E184.
41. Ikeda, H. and Murase, K., Glial nitric oxide-mediated long-term presynaptic facilitation revealed by optical imaging in rat spinal dorsal horn. J. Neurosci. 2004, 24: 9888-9896.
42. Johnson, P.C., Doll, S.C. and Cromey, D.W., Pathogenesis of diabetic neuropathy. Ann. Neurol. 1986, 19: 450-457.
43. Kapoor, R., Davies, M., Blaker, P.A., Hall, S.M. and Smith, K.J., Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann. Neurol. 2003, 53: 174-180.
44. Kawabata, A., Manabe, S., Manabe, Y. and Takagi, H., Effect of topical administration of L-arginine on formalin- induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol. 1994, 112: 547-550.
45. Keilhoff, G., Fansa, H. and Wolf, G., Differences in peripheral nerve degeneration/regeneration between wild-type and neuronal nitric oxide synthase knockout mice. J. Neurosci. Res. 2002, 68: 432-441.
46. Keilhoff, G., Fansa, H. and Wolf, G., Nitric oxide synthase, an essential factor in peripheral nerve regeneration. Cell. Mol. Biol. 2003, 49: 885-897.
47. Keilhoff, G., Wolf, G. and Fansa, H., NOS-mediated differences in peripheral nerve graft revascularization and regeneration. NeuroReport 2002, 13: 1463-1468.
48. Kennedy, J.M.,Rubin, I.,Lauritzen, M.and Zochodne, D.W. Injury-induced nitric oxide synthase activity in regenerating diabetic peripheral nerves. Soc. Neurosci. Abs. 2002, 31: 449.
49. Kennedy, J.M. and Zochodne, D.W., The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain 2000, 123: 2118-2129.
50. Kennedy, J.M. and Zochodne, D.W., Influence of experimental diabetes on the microcirculation of injured peripheral nerve. Functional and morphological aspects. Diabetes 2002, 51: 2233-2240.
51. Kihara, M. and Low, P.A., Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp. Neurol. 1995, 132: 180-185.
52. Kim, K.J., Yoon, Y.W. and Chung, J.M., Comparison of three rodent neuropathic pain models. Exp. Brain Res. 1997, 113: 200-206.
53. Kim, S.H. and Chung, J.M., An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50: 355-363.
54. Kowluru, R., Bitensky M.W., Kowluru, A., Dembo, M., Keaton, P.A. and Buican, T., Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy. Proc. Natl. Acad. Sci. USA 1989, 86: 3327-3331.
55. Lawrence, E. and Brain, S.D., Altered microvascular reactivity to endothelin-1, endothelin-3 and NG-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 1992, 106: 1035-1040.
56. Lee, Y. and Shin, T., Expression of constitutive endothelial and inducible nitric oxide synthase in the sciatic nerve of Lewis rats with experimental autoimmune neuritis. J. Neuroimmunol. 2002, 126: 78-85.
57. Levy, D., Hoke, A. and Zochodne, D.W., Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci. Lett. 1999, 260: 207-209.
58. Levy, D., Kubes, P. and Zochodne, D.W., Delayed peripheral nerve degeneration, regeneration and pain in mice lacking inducible nitric oxide synthase. J. Neuropathol. Exp. Neurol. 2001, 60: 411-421.
59. Levy, D. and Strassman, A.M., Modulation of dural nociceptor mechanosensitivity by the nitric oxide-cyclic GMP signaling cascade. J. Neurophysiol. 2004, 92: 766-772.
60. Levy, D., Tal, M., Hoke, A. and Zochodne, D.W., Transient action of the endothelial constitutive nitric oxide synthase (ecNOS) mediates the development of thermal hypersensitivity following peripheral nerve injury. Eur. J. Neurosci. 2000, 12: 2323-2332.
61. Levy, D. and Zochodne, D.W., Local nitric oxide synthase activity in a model of neuropathic pain. Eur. J. Neurosci. 1998, 10: 1846-1855.
62. Lincoln, J., Hoyle, C.H. and Burnstock, G., Nitric Oxide in Health and Disease. Cambridge University Press, 1997.
63. Low, P.A., Lagerlund, T.D. and McManis, P.G., Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int. Rev. Neurobiol. 1989, 31: 355-438.
64. Low, P.A. and Nickander, K.K., Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 1991, 40: 873-877.
65. Low, P.A., Nickander, K.K. and Tritschler, H.J., The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997, 46: S38-S42.
66. Low, P.A. and Tuck, R.R., Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J. Physiol. 1984, 347: 513-524.
67. Malik, R.A., The pathology of human diabetic neuropathy. Diabetes 1997, 46: S50-S53.
68. Malik, R.A., Newrick, P.G., Sharma, A.K., Jennings, A., Ah-See, A.K., Mayhew, T.M., Jakubowski, J., Boulton, A.J. and Ward, J.D., Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989, 32: 92-102.
69. Malik, R.A., Tesfaye, S., Thompson, S.D., Veves, A., Sharma, A.K., Boulton, A.J.M. and Ward, J.D., Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 1993, 36: 454-459.
70. Malik, R.A., Veves, A., Masson, E.A., Sharma, A.K., Ah-See, A.K., Schady W., Lye, R.H. and Boulton, A.J., Endoneurial capillary abnormalities in mild human diabetic neuropathy. J. Neurol. Neurosurg. Psychiatry 1992, 55: 557-561.
71. Mayhan, W.G., Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 1989, 256: H621-H625.
72. McDonald, D. and Zochodne, D.W., Improved periheral nerve regeneration with local inhibition of nitric oxide synthesis. Soc. Neurosci. Abs. 2001, 871.6: YY-26.
73. Meller, S.T., Cummings, C.P., Traub, R.J. and Gebhart, G.F., The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 1994, 60: 367-374.
74. Meller, S.T., Pechman, P.S., Gebhart, G.F. and Maves, T.J., Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience 1992, 50: 7-10.
75. Olesen, J., Thomsen, L.L. and Iversen, H., Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol. Sci. 1994, 15: 149-153.
76. Pereira, E.C., Neto, H.S. and Marques, M.J., Immunolocalisation of neuronal nitric oxide synthase at the neuromuscular junction of MDX mice: a confocal microscopy study. J. Anat. 2001, 198: 663-671.
77. Prado, W.A., Schiavon, V.F. and Cunha, F.Q., Dual effect of local application of nitric oxide donors in a model of incision pain in rats. Eur. J. Pharmacol. 2002, 441: 57-65.
78. Pugliese, G., Tilton, R.G., Speedy, A., Chang, K., Santarelli, E., Province, M.A., Eades, D., Sherman, W.R. and Williamson, J.R., Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats. Diabetologia 1989, 32: 845-857.
79. Qian, Y., Chao, D.S., Santillano, D.R., Cornwell, T.L., Nairn, A.C., Greengard, P., Lincoln, T.M. and Bredt, D.S., cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons. J. Neurosci. 1996, 16: 3130-3138.
80. Quayle, J.M., Bonev, A.D., Brayden, J.E. and Nelson, M.T., Calcitonin gene-related peptide activated ATP-sensitive K+ currents in rabbit arterial smooth muscle via protein kinase A. J. Physiol. 1994, 475(1): 9-13.
81. Redford, E.J., Kapoor, R. and Smith, K.J., Nitric oxide donors reversibily block axonal conduction: demyelinated axons are especially susceptible. Brain 1997, 120: 2149-2157.
82. + channels in C-type DRG neurons by S-nitrosylation. J. Neurophysiol. 2002, 87: 761-775.
83. Rivot, J.P., Barraud, J., Montecot, C., Jost, B. and Besson, J.M., Nitric oxide (NO): in vivo electrochemical monitoring in the dorsal horn of the spinal cord of the rat. Brain Res. 1997, 773: 66-75.
84. Rivot, J.P., Montagne-Clavel, J. and Besson, J.M., Subcutaneous formalin and intraplantar carrageenan increase nitric oxide release as measured by in vivo voltammetry in the spinal cord. Eur. J. Pain 1997, 6: 25-34.
85. Roche, A.K., Cook, M., Wilcox, G.L. and Kajander, K.C., A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammation. Pain 1996, 66: 331-341.
86. Sayan, H., Ugurlu, B., Babul, A., Take, G. and Erdogan, D., Effects of L-arginine and NG-nitro L-arginine methyl ester on lipid peroxide, superoxide dismutase and nitrate levels after experimental sciatic nerve ischemia-reperfusion in rats. Int. J. Neurosci. 2004, 114: 349-364.
87. Simpson, L.O., Altered blood rheology in the pathogenesis of diabetic and other neuropathies. Muscle Nerve 1988, 11: 725-744.
88. Smith, K.J., Kapoor, R., Hall, S.M. and Davies, M., Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol. 2001, 49: 470-476.
89. Sommer, C.,Zelenka M,Marziniak, M.,Schafers, M.and Vogel, C. Pain related behavior in eNOS-deficient mice. J. Peripher. Nerv. Syst. 2003, 8: 61-61.
90. Stevens, E.J., Carrington, A.L. and Tomlinson, D.R., Nerve ischemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia 1994, 37: 43-48.
91. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J. Clin. Invest. 1994, 94: 853-859.
92. Tesfamariam, B., Palacino, J.J., Weisbrod, R.M. and Cohen, R.A., Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J. Cardiovasc. Pharmacol. 1993, 21: 205-211.
93. Theriault, M., Dort, J., Sutherland, G. and Zochodne, D.W., Local human sural nerve blood flow in diabetic and other polyneuropathies. Brain 1997, 120: 1131-1138.
94. Thomsen, K., Rubin, I. and Lauritzen, M., NO- and non-NO-, non-prostanoid-dependent vasodilatation in rat sciatic nerve during maturation and developing experimental diabetic neuropathy. J. Physiol. 2002, 543: 977-993.
95. Tilton, R.G., Chang, K., Hasan, K.S., Smith, S.R., Petrash, J.M., Misko, T.P., Moore, W.M., Currie, M.G., Corbett, J.A., McDaniel, M.L. and Williamson, J.R., Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993, 42: 221-232.
96. Timperley W.R., Boulton, A.J., Davies-Jones, G.A., Jarratt, J.A. and Ward, J.D., Small vessel disease in progressive diabetic neuropathy associated with good metabolic control. J. Clin. Pathol. 1985, 38: 1030-1038.
97. Tolins, J.P., Schultz, P.J., Raij, L., Brown, D.M. and Mauer, S.M., Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am. J. Physiol. 1993, 265: F886-F895.
98. Tonussi, C.R. and Ferreira, S.H., Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur. J. Pharmacol. 1994, 251: 173-179.
99. Truong, W., Cheng, C., Xu, Q.G., Li, X.Q. and Zochodne, D.W., Mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann. Neurol. 2003, 53: 366-375.
100. Tuck, R.R., Schmelzer, J.D. and Low, P.A., Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984, 107: 935-950.
101. Van, D., V and Roberts, L.J., Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids. J. Neuroimmunol. 1999, 95: 1-7.
102. Verge, V.M.K., Xu, Z., Xu, X.J., Wiesenfeld-Hallin, Z. and Hokfelt, T., Marked increase in nitric oxide synthase mRNA in rat dorsal root ganglia after peripheral axotomy: in situ hybridization and functional studies. Proc. Natl. Acad. Sci. USA 1992, 89: 11617-11621.
103. Vernet, D., Cai, L., Garban, H., Babbitt, M.L., Murray, F.T., Rajfer, J. and Gonzalez-Cadavid, N.F., Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 1995, 136: 5709-5717.
104. Vizzard, M.A., Erdman, S.L. and de Groat, W.C., Increased expression of neuronal nitric oxide synthase (NOS) in visceral neurons after nerve injury. J. Neurosci. 1995, 15: 4033-4045.
105. Waller, A., Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog and observations of the alterations produced thereby in the structure of their primitive fibers. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 1850, 140: 423-429.
106. Wang, M., Wu, Y., Culver, D.G. and Glass, J.D., The gene for slow Wallerian degeneration (Wlds)) is also protective against vincristine neuropathy. Neurobiol. Dis. 2001, 8: 155-161.
107. Ward, K.K., Low, P.A., Schmelzer, J.D. and Zochodne, D.W., Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 1989, 112: 197-208.
108. Wiesenfeld-Hallin, Z., Hao, J.X., Xu, X.J. and Hokfelt, T., Nitric oxide mediates ongoing discharges in dorsal root ganglion cells after peripheral nerve injury. J. Neurophysiol. 1993, 70: 2350-2353.
109. Williams, E., Timperley W.R., Ward, J.D. and Duckworth, T., Electron microscopical studies of vessels in diabetic peripheral neuropathy. J. Clin. Pathol. 1980, 33: 462-470.
110. Williamson, J.R., Ostrow, V., Eades, D., Chang, K., Allison, W., Kilo, C. and Sherman, W.R., Glucoe-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevents by an aldose reductase inhibitor. J. Clin. Invest. 1990, 85: 1167-1172.
111. Wu, J., Lin, Q., McAdoo, D.J. and Willis, W.D., Nitric oxide contributes to central sensitization following intradermal injection of capsaicin. NeuroReport 1998, 9: 589-592.
112. Xu, Q.-G., Cheng, C., Sun, H., Thomsen, K. and Zochodne, D.W., Local sensory ganglion ischemia induced by endothelin vasoconstriction. Neuroscience 2003, 122: 897-905.
113. Yasuda, H. and Dyck, P.J., Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 1987, 37: 20-28.
114. 1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced didabetic rats Comparison with aldose reductase inhibitor ONO 2235. Diabetes 1989, 38: 832-838.
115. Yu, W.H., Nitric oxide synthase in motor neurons after axotomy. J. Histochem. Cytochem. 1994, 42: 451-457.
116. Zochodne, D.W., Allison, J.A., Ho, W., Ho, L.T., Hargreaves, K. and Sharkey K.A., Evidence for CGRP accumulation and activity in experimental neuromas. Am. J. Physiol. 1995, 268: H584-H590.
117. Zochodne, D.W. and Cheng, C., Diabetic peripheral nerves are susceptible to multifocal ischemic damage from endothelin. Brain Res. 1999, 838: 11-17.
118. Zochodne, D.W., Cheng, C., Miampamba, M., Hargreaves, K. and Sharkey, K.A., Peptide accumulations in proximal endbulbs of transected axons. Brain Res. 2001, 902: 40-50.
119. Zochodne, D.W., Cheng, C. and Sun, H., Diabetes increases sciatic nerve susceptibility to endothelin- induced ischemia. Diabetes 1996, 45: 627-632.
120. Zochodne, D.W. and Ho, L.T., Endoneurial microenvironment and acute nerve crush injury in the rat sciatic nerve. Brain Res. 1990, 535: 43-48.
121. Zochodne, D.W. and Ho, L.T., Hyperemia of injured peripheral nerve: sensitivity to CGRP antagonism. Brain Res. 1992, 598: 59-66.
122. Zochodne, D.W. and Ho, L.T., Normal blood flow but lower oxygen tension in diabetes of young rats: microenvironment and the influence of sympathectomy. Can. J. Physiol. Pharmacol. 1992, 70: 651-659.
123. Zochodne, D.W. and Ho, L.T., The influence of indomethacin and guanethidine on experimental streptozotocin diabetic neuropathy. Can. J. Neurol. Sci. 1992, 19: 433-441.
124. Zochodne, D.W. and Ho, L.T., Diabetes mellitus prevents capsaicin from inducing hyperaemia in the rat sciatic nerve. Diabetologia 1993, 36: 493-496.
125. Zochodne, D.W., Ho, L.T. and Allison, J.A., Dorsal root ganglia microenvironment of female BB Wistar diabetic rats with mild neuropathy. J. Neurol. Sci. 1994, 127: 36-42.
126. Zochodne, D.W., Levy, D., Zwiers, H., Sun, H., Rubin, I., Cheng, C. and Lauritzen, M., Evidence for nitric oxide and nitric oxide synthase activity in proximal stumps of transected peripheral nerves. Neuroscience 1999, 91: 1515-1527.
127. Zochodne, D.W., Misra, M., Cheng, C. and Sun, H., Inhibition of nitric oxide synthase enhances peripheral nerve regeneration in mice. Neurosci. Lett. 1997, 228: 71-74.
128. Zochodne, D.W. and Nguyen, C., Increased peripheral nerve microvessels in early experimental diabetic neuropathy: quantitative studies of nerve and dorsal root ganglia. J. Neurol. Sci. 1999, 166: 40-46.
129. Zochodne, D.W., Sun, H. and Li, X.Q., Evidence that nitric oxide and opioid containing inerneurons innervate vessels in the dorsal horn of the spinal cord of rats. J. Physiol. 2001, 532: 749-758.
130. Zochodne, D.W., Verge, V.M., Cheng, C., Hoke, A., Jolley C., Thomsen, K., Rubin, I. and Lauritzen, M., Nitric oxide synthase activity and expression in experimental diabetic neuropathy. J. Neuropathol. Exp. Neurol. 2000, 59: 798-807.